These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30454027)

  • 1. Sortilin inhibition limits secretion-induced progranulin-dependent breast cancer progression and cancer stem cell expansion.
    Rhost S; Hughes É; Harrison H; Rafnsdottir S; Jacobsson H; Gregersson P; Magnusson Y; Fitzpatrick P; Andersson D; Berger K; Ståhlberg A; Landberg G
    Breast Cancer Res; 2018 Nov; 20(1):137. PubMed ID: 30454027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer.
    Berger K; Rhost S; Rafnsdóttir S; Hughes É; Magnusson Y; Ekholm M; Stål O; Rydén L; Landberg G
    BMC Cancer; 2021 Feb; 21(1):185. PubMed ID: 33618683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of Progranulin-Induced Breast Cancer Stem Cell Propagation by Sortilin-Targeting Cyclotriazadisulfonamide (CADA) Compounds.
    Berger K; Pauwels E; Parkinson G; Landberg G; Le T; Demillo VG; Lumangtad LA; Jones DE; Islam MA; Olsen R; Kapri T; Intasiri A; Vermeire K; Rhost S; Bell TW
    J Med Chem; 2021 Sep; 64(17):12865-12876. PubMed ID: 34428050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-Species Differences in Regulation of the Progranulin-Sortilin Axis in TDP-43 Cell Models of Neurodegeneration.
    Gumina V; Onesto E; Colombrita C; Maraschi A; Silani V; Ratti A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The perlecan-interacting growth factor progranulin regulates ubiquitination, sorting, and lysosomal degradation of sortilin.
    Tanimoto R; Palladino C; Xu SQ; Buraschi S; Neill T; Gomella LG; Peiper SC; Belfiore A; Iozzo RV; Morrione A
    Matrix Biol; 2017 Dec; 64():27-39. PubMed ID: 28433812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sortilin regulates progranulin action in castration-resistant prostate cancer cells.
    Tanimoto R; Morcavallo A; Terracciano M; Xu SQ; Stefanello M; Buraschi S; Lu KG; Bagley DH; Gomella LG; Scotlandi K; Belfiore A; Iozzo RV; Morrione A
    Endocrinology; 2015 Jan; 156(1):58-70. PubMed ID: 25365768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of progranulin expression and location by sortilin in oxygen-glucose deprivation/reoxygenation injury.
    Wang Y; Wang X; Li Y; Chen D; Liu Z; Zhao Y; Tu L; Wang S
    Neurosci Lett; 2020 Nov; 738():135394. PubMed ID: 32949659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 Induces Stem Cell Propagation through Liaison with the Sortilin-Progranulin Axis in Breast Cancer.
    Berger K; Persson E; Gregersson P; Ruiz-Martínez S; Jonasson E; Ståhlberg A; Rhost S; Landberg G
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Interaction Between Progranulin with Sortilin and the Lysosome.
    Zhou X; Sullivan PM; Paushter DH; Hu F
    Methods Mol Biol; 2018; 1806():269-288. PubMed ID: 29956282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The identification of AF38469: an orally bioavailable inhibitor of the VPS10P family sorting receptor Sortilin.
    Schrøder TJ; Christensen S; Lindberg S; Langgård M; David L; Maltas PJ; Eskildsen J; Jacobsen J; Tagmose L; Simonsen KB; Biilmann Rønn LC; de Jong IE; Malik IJ; Karlsson JJ; Bundgaard C; Egebjerg J; Stavenhagen JB; Strandbygård D; Thirup S; Andersen JL; Uppalanchi S; Pervaram S; Kasturi SP; Eradi P; Sakumudi DR; Watson SP
    Bioorg Med Chem Lett; 2014 Jan; 24(1):177-80. PubMed ID: 24355129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potent inhibitors of the sortilin-progranulin interaction.
    Stachel SJ; Ginnetti AT; Johnson SA; Cramer P; Wang Y; Bukhtiyarova M; Krosky D; Stump C; Hurzy DM; Schlegel KA; Cooke AJ; Allen S; O'Donnell G; Ziebell M; Parthasarathy G; Getty KL; Ho T; Ou Y; Jovanovska A; Carroll SS; Pausch M; Lumb K; Mosser SD; Voleti B; Klein DJ; Soisson SM; Zerbinatti C; Coleman PJ
    Bioorg Med Chem Lett; 2020 Sep; 30(17):127403. PubMed ID: 32738972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells.
    Lawson DA; Bhakta NR; Kessenbrock K; Prummel KD; Yu Y; Takai K; Zhou A; Eyob H; Balakrishnan S; Wang CY; Yaswen P; Goga A; Werb Z
    Nature; 2015 Oct; 526(7571):131-5. PubMed ID: 26416748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TH1902, a new docetaxel-peptide conjugate for the treatment of sortilin-positive triple-negative breast cancer.
    Demeule M; Charfi C; Currie JC; Larocque A; Zgheib A; Kozelko S; Béliveau R; Marsolais C; Annabi B
    Cancer Sci; 2021 Oct; 112(10):4317-4334. PubMed ID: 34314556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-induced secretion stimulates breast cancer stem cell regulatory signalling pathways.
    Jacobsson H; Harrison H; Hughes É; Persson E; Rhost S; Fitzpatrick P; Gustafsson A; Andersson D; Gregersson P; Magnusson Y; Ståhlberg A; Landberg G
    Mol Oncol; 2019 Aug; 13(8):1693-1705. PubMed ID: 31066211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An anti-sortilin affibody-peptide fusion inhibits sortilin-mediated progranulin degradation.
    Ek M; Nilvebrant J; Nygren PÅ; Ståhl S; Lindberg H; Löfblom J
    Front Immunol; 2024; 15():1437886. PubMed ID: 39185427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iPSC-Derived Hereditary Breast Cancer Model Reveals the
    Portier L; Desterke C; Chaker D; Oudrhiri N; Asgarova A; Dkhissi F; Turhan AG; Bennaceur-Griscelli A; Griscelli F
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted manipulation of the sortilin-progranulin axis rescues progranulin haploinsufficiency.
    Lee WC; Almeida S; Prudencio M; Caulfield TR; Zhang YJ; Tay WM; Bauer PO; Chew J; Sasaguri H; Jansen-West KR; Gendron TF; Stetler CT; Finch N; Mackenzie IR; Rademakers R; Gao FB; Petrucelli L
    Hum Mol Genet; 2014 Mar; 23(6):1467-78. PubMed ID: 24163244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminus of progranulin interacts with the beta-propeller region of sortilin to regulate progranulin trafficking.
    Zheng Y; Brady OA; Meng PS; Mao Y; Hu F
    PLoS One; 2011; 6(6):e21023. PubMed ID: 21698296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes.
    Balamurugan K; Mendoza-Villanueva D; Sharan S; Summers GH; Dobrolecki LE; Lewis MT; Sterneck E
    Oncogene; 2019 May; 38(20):3765-3780. PubMed ID: 30262865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.